<SEC-DOCUMENT>0001753926-23-000939-index.html : 20230720
<SEC-HEADER>0001753926-23-000939.hdr.sgml : 20230720
<ACCEPTANCE-DATETIME>20230719211501
ACCESSION NUMBER:		0001753926-23-000939
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20230720
DATE AS OF CHANGE:		20230719

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chromocell Therapeutics Corp
		CENTRAL INDEX KEY:			0001919246
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				863335449
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-269188
		FILM NUMBER:		231097942

	BUSINESS ADDRESS:	
		STREET 1:		685 US HIGHWAY ONE
		CITY:			NORTH BRUNSWICK
		STATE:			NJ
		ZIP:			08902
		BUSINESS PHONE:		9176446313

	MAIL ADDRESS:	
		STREET 1:		685 US HIGHWAY ONE
		CITY:			NORTH BRUNSWICK
		STATE:			NJ
		ZIP:			08902
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>g083645_s1a.htm
<DESCRIPTION>S-1/A
<TEXT>
Document 1 - file: g083645_s1a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.4
<SEQUENCE>2
<FILENAME>g083645_ex3-4.htm
<DESCRIPTION>EXHIBIT 3.4
<TEXT>
Document 2 - file: g083645_ex3-4.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>g083645_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
Document 3 - file: g083645_ex4-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>4
<FILENAME>g083645_ex4-2.htm
<DESCRIPTION>EXHIBIT 4.2
<TEXT>
Document 4 - file: g083645_ex4-2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>g083645_ex10-4.htm
<DESCRIPTION>EXHIBIT 10.4
<TEXT>
Document 5 - file: g083645_ex10-4.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>g083645_ex10-5.htm
<DESCRIPTION>EXHIBIT 10.5
<TEXT>
Document 6 - file: g083645_ex10-5.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>7
<FILENAME>g083645_ex10-6.htm
<DESCRIPTION>EXHIBIT 10.6
<TEXT>
Document 7 - file: g083645_ex10-6.htm

</DOCUMENT>
</SEC-DOCUMENT>